Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
2
AIO-Studien-gGmbH
1
Ipsen
1
Janssen Research & Development, LLC
1
Leipzig Heart Institute GmbH
1
Straub Medical AG
1
Clinical Trials at Elblandklinikum Riesa
During the past decade, Elblandklinikum Riesa conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.
Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer
2019-10-24
2029-01-01
Active, not recruiting
471
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Elblandklinikum Riesa" #1 sponsor was "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials, followed by "AIO-Studien-gGmbH" with 1 trials
sponsored, "Ipsen" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Leipzig Heart Institute GmbH"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Elblandklinikum Riesa"
#1 collaborator was "Celgene" with 1 trials as a collaborator, "Crolll Gmbh" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator and "Servier Deutschland GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Elblandklinikum Riesa
According to Clinical.Site data, the most researched conditions in "Elblandklinikum Riesa" are
"Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Chronic Heart Failure" (1 trials), "Locally Advanced Pancreatic Cancer" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Metastatic Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Elblandklinikum Riesa" in a lesser frequency.
Clinical Trials Intervention Types at Elblandklinikum Riesa
Most popular intervention types in "Elblandklinikum Riesa" are "Drug" (2 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Archival Tumor Tissue Sample" (1 trials), "Atherectomy/Thrombectomy" (1 trials), "CRT-D implantation" (1 trials), "CRT-P implantation" (1 trials) and "FerInject" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Elblandklinikum Riesa
The vast majority of trials in "Elblandklinikum Riesa" are
7 trials for "All" genders.
Clinical Trials Status at Elblandklinikum Riesa
Currently, there are NaN active trials in "Elblandklinikum Riesa".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Elblandklinikum Riesa,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Elblandklinikum Riesa, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".